AI assistant
Sending…
RESMED INC — Director's Dealing 2011
Jul 18, 2011
30071_dirs_2011-07-18_37ba57f5-58d0-486d-8bed-a17a1f183ca4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2011-07-14
Reporting Person: Sandercock Brett (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-07-14 | ResMed Common Stock | M | 50000 | $21.025 | Acquired | 100111.86 | Direct |
| 2011-07-14 | ResMed Common Stock | S | 50000 | $32.50 | Disposed | 50111.86 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-07-14 | ResMed Common Stock Options | $21.025 | M | 50000 | Disposed | 2014-11-07 | ResMed Common Stock (50000) | Direct |
Footnotes
F1: This transaction was done in accordance with a 10b5-1 trading plan.
F2: Represents first day options became exercisable.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29